Atlas Trials

POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock

Clinical trial NCT03953404 · UNKNOWN

Trial details

NCT number
NCT03953404
Sponsor
St. Luke's Hospital, Pennsylvania
Status
UNKNOWN
Study type
OBSERVATIONAL
Sepsis
Start date
2019-05-14
Primary completion
2020-04-30
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.